Table I.
Baseline characteristics: Non-diabetics and Diabetics
| Characteristic | No history of Diabetes (N=194) Mean (±SD); N(%) Median (IQR) |
History of Diabetes (N=56) Mean (±SD); N(%) Median (IQR) |
Total (N=250) Mean (±SD); N(%) Median (IQR) |
|---|---|---|---|
| Age | 71 (±7.6) | 70 (±6.5) | 71 (±7.3) |
| Sex | |||
| Male | 165 (85%) | 50 (89%) | 215 (86%) |
| Female | 29 (15%) | 6 (11%) | 35 (14%) |
| BMI** | 28.4 (±5.2) | 31.2 (±4.4) | 29 (±5.1) |
| Race | |||
| White | 176 (90.7%) | 53 (94.6) | 229 (91.6%) |
| Non-white | 18 (9.3%) | 3 (5.4%) | 21 (8.4%) |
| Smoking | |||
| Never used | 15 (7.7%) | 4 (7.1%) | 19 (7.6) |
| Current user/quit in last year | 69 (35.6%) | 15 (26.8%) | 84 (33.6%) |
| Former user | 110 (56.7%) | 37 (66.1%) | 147 (58.8%) |
| Hypercholesterolemia* | 145 (74.7%) | 51 (91.1%) | 196 (78.4%) |
| CAD* | 74 (38.1%) | 30 (53.6%) | 104 (41.6%) |
| Cancer* | 70 (36.1%) | 11 (19.6%) | 81 (32.4%) |
| COPD | 46 (23.7%) | 13 (23.2%) | 59 (23.6%) |
| Family history AAA | 39 (20.1%) | 8 (14.3%) | 47 (18.8%) |
| Atrial Fibrillation | 23 (11.9%) | 9 (16.1%) | 32 (12.8%) |
| CHF* | 11 (5.7%) | 8 (14.3%) | 19 (7.6%) |
| Medications | |||
| Statin** | 151 (77.8%) | 54 (96.4%) | 205 (82.0%) |
| Beta blocker | 95 (49.0%) | 35 (62.5%) | 130 (52%) |
| ACE inhibitor* | 61 (31.4%) | 26 (46.4%) | 87 (34.8%) |
| ARB* | 29 (15%) | 16 (28.6%) | 45 (18%) |
| CCB | 43 (22.2%) | 16 (28.6%) | 59 (23.6%) |
| Daily ASA | 130 (67%) | 45 (80.4%) | 175 (70%) |
| Other anti-platelet | 33 (17.0%) | 10 (17.9%) | 43 (17.2%) |
| Any anti-platelet* | 137 (70.6%) | 49 (87.5%) | 186 (74.4%) |
| Diuretic** | 52 (26.8%) | 29 (51.8%) | 81 (32.4%) |
| Baseline MTD (cm) | 4.30 (±0.41) | 4.32 (±0.45) | 4.30 (±0.42) |
| Males | 4.35 (±0.40) | 4.34 (±0.47) | 4.35 (±0.42) |
| Females | 3.97 (±0.32) | 4.16 (±0.26) | 4.00 (±0.32) |
| Repairs | 19 (9.8%) | 3 (5.4%) | 22 (8.8%) |
| Death | 4 (2%) | 1 (1.8%) | 5 (2%) |
| CRP (mg/L) | 2.53 (1.19-4.68) | 2.1 (1.31-3.82) | 2.34 (1.20-4.56) |
| MMP-9 (ng/mL) | 38.90 (26.53-59.82) | 34.43 (27.87-45.20) | 37.86 (27.18-56.83) |
| SAA (mg/L) | 19.15 (10.80-40.40) | 22.97 (14.04-40.66) | 20.70 (12.04-40.40) |
*
p<0.05
**
p<0.005
Interquartile range (IQR), standard deviation (SD)